Drug action(s), drug marketing, and clinical medicine : suppression of ventricular arrhythmogenicity with if blockade in human heart failure : emerging clinical evidence for ivabradine treatment benefit beyond heart rate control

2017
journal article
other documents
3
cris.lastimport.wos2024-04-09T20:57:46Z
dc.affiliationWydział Lekarski : Instytut Kardiologiipl
dc.cm.date2020-01-07
dc.cm.id87048
dc.contributor.authorMusiałek, Piotr - 173944 pl
dc.date.accessioned2020-01-17T09:20:27Z
dc.date.available2020-01-17T09:20:27Z
dc.date.issued2017pl
dc.date.openaccess0
dc.description.accesstimew momencie opublikowania
dc.description.number12pl
dc.description.physical1368-1371pl
dc.description.points15pl
dc.description.versionostateczna wersja wydawcy
dc.description.volume75pl
dc.identifier.doi10.5603/KP.2017.0238pl
dc.identifier.eissn1897-4279pl
dc.identifier.issn0022-9032pl
dc.identifier.projectROD UJ / OPpl
dc.identifier.urihttps://ruj.uj.edu.pl/xmlui/handle/item/142322
dc.languageengpl
dc.language.containerengpl
dc.rightsUdzielam licencji. Uznanie autorstwa - Użycie niekomercyjne - Bez utworów zależnych 4.0 Międzynarodowa*
dc.rights.licenceCC-BY-NC-ND
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/legalcode.pl*
dc.share.typeotwarte czasopismo
dc.subtypeOtherDocumentspl
dc.titleDrug action(s), drug marketing, and clinical medicine : suppression of ventricular arrhythmogenicity with if blockade in human heart failure : emerging clinical evidence for ivabradine treatment benefit beyond heart rate controlpl
dc.title.journalKardiologia Polska = Polish Heart Journalpl
dc.typeJournalArticlepl
dspace.entity.typePublication
cris.lastimport.wos
2024-04-09T20:57:46Z
dc.affiliationpl
Wydział Lekarski : Instytut Kardiologii
dc.cm.date
2020-01-07
dc.cm.id
87048
dc.contributor.authorpl
Musiałek, Piotr - 173944
dc.date.accessioned
2020-01-17T09:20:27Z
dc.date.available
2020-01-17T09:20:27Z
dc.date.issuedpl
2017
dc.date.openaccess
0
dc.description.accesstime
w momencie opublikowania
dc.description.numberpl
12
dc.description.physicalpl
1368-1371
dc.description.pointspl
15
dc.description.version
ostateczna wersja wydawcy
dc.description.volumepl
75
dc.identifier.doipl
10.5603/KP.2017.0238
dc.identifier.eissnpl
1897-4279
dc.identifier.issnpl
0022-9032
dc.identifier.projectpl
ROD UJ / OP
dc.identifier.uri
https://ruj.uj.edu.pl/xmlui/handle/item/142322
dc.languagepl
eng
dc.language.containerpl
eng
dc.rights*
Udzielam licencji. Uznanie autorstwa - Użycie niekomercyjne - Bez utworów zależnych 4.0 Międzynarodowa
dc.rights.licence
CC-BY-NC-ND
dc.rights.uri*
http://creativecommons.org/licenses/by-nc-nd/4.0/legalcode.pl
dc.share.type
otwarte czasopismo
dc.subtypepl
OtherDocuments
dc.titlepl
Drug action(s), drug marketing, and clinical medicine : suppression of ventricular arrhythmogenicity with if blockade in human heart failure : emerging clinical evidence for ivabradine treatment benefit beyond heart rate control
dc.title.journalpl
Kardiologia Polska = Polish Heart Journal
dc.typepl
JournalArticle
dspace.entity.type
Publication
Affiliations

* The migration of download and view statistics prior to the date of April 8, 2024 is in progress.

Views
10
Views per month
Views per city
Ashburn
3
Wroclaw
2
Des Moines
1
Dublin
1
Downloads
musialek_drug_actions_drug_marketing_and_clinical_medicine_2017.odt
1
musialek_drug_actions_drug_marketing_and_clinical_medicine_2017.pdf
1